- Home
- CAAP vs SVA Comparison
CAAP vs SVA Comparison
Compare CAAP & SVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAAP
- SVA
- Stock Information
- Founded
- CAAP 1998
- SVA N/A
- Country
- CAAP Luxembourg
- SVA
- Employees
- CAAP N/A
- SVA 3261
- Industry
- CAAP Aerospace
- SVA
- Sector
- CAAP Consumer Discretionary
- SVA
- Exchange
- CAAP Nasdaq
- SVA NYSE
- Market Cap
- CAAP N/A
- SVA N/A
- IPO Year
- CAAP 2018
- SVA N/A
- Fundamental
- Price
- CAAP $20.48
- SVA $6.47
- Analyst Decision
- CAAP Strong Buy
- SVA
- Analyst Count
- CAAP 2
- SVA 0
- Target Price
- CAAP $23.60
- SVA N/A
- AVG Volume (30 Days)
- CAAP 171.9K
- SVA N/A
- Earning Date
- CAAP 05-22-2025
- SVA N/A
- Dividend Yield
- CAAP N/A
- SVA N/A
- EPS Growth
- CAAP N/A
- SVA N/A
- EPS
- CAAP 1.05
- SVA N/A
- Revenue
- CAAP $1,858,038,000.00
- SVA N/A
- Revenue This Year
- CAAP $0.09
- SVA N/A
- Revenue Next Year
- CAAP $12.90
- SVA N/A
- P/E Ratio
- CAAP $19.27
- SVA N/A
- Revenue Growth
- CAAP 28.46
- SVA N/A
- 52 Week Low
- CAAP $13.97
- SVA N/A
- 52 Week High
- CAAP $22.13
- SVA N/A
- Technical
- Relative Strength Index (RSI)
- CAAP 50.07
- SVA N/A
- Support Level
- CAAP $20.17
- SVA N/A
- Resistance Level
- CAAP $20.88
- SVA N/A
- Average True Range (ATR)
- CAAP 0.63
- SVA 0.00
- MACD
- CAAP -0.21
- SVA 0.00
- Stochastic Oscillator
- CAAP 32.78
- SVA 0.00
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.